2018 annual financial data
Capricor Therapeutics 2018 Operating margin
Direct answer
Operating margin was -917.04%.
Operating income was -15,327,086 USD and net income was -15,191,095 USD.
Operating cash flow was -13,862,441 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,671,356 USD
- Operating income
- -15,327,086 USD
- Net income
- -15,191,095 USD
- Operating cash flow
- -13,862,441 USD